Skip to main content
PLOS One logoLink to PLOS One
. 2020 Jun 5;15(6):e0234131. doi: 10.1371/journal.pone.0234131

Effects of castration on atherosclerosis in Yucatan minipigs with genetic hypercholesterolemia

Jeong T Shim 1,2, Nikolaj Schmidt 1, Paula Nogales 2, Torben Larsen 3, Charlotte B Sørensen 1, Jacob F Bentzon 1,2,*
Editor: Michael Bader4
PMCID: PMC7274396  PMID: 32502216

Abstract

Background

Low plasma testosterone, either spontaneous or as a result of androgen deprivation therapy for prostate cancer, is associated with an increased risk of cardiovascular events. The underlying mechanism in humans is not understood. Experimental studies in mice have shown that castration facilitates atherogenesis and may increase signs of plaque vulnerability. Pigs used for translational atherosclerosis research have frequently been castrated for practical or commercial reasons, but the effect of castration on atherosclerosis has never been systematically evaluated in pigs.

Objective

To study the effect of castration on atherosclerotic plaque burden and type in genetically modified minipigs with hypercholesterolemia.

Methods

Newborn male Yucatan minipigs with transgenic overexpression of a human gain-of-function mutant of proprotein convertase subtilisin/kexin type 9 were randomized to undergo orchiectomy (n = 8) or serve as controls (n = 6). Minipigs were started on high-fat diet at 3 months of age and the amount and composition of atherosclerotic lesions were analyzed at 12 months of age. Plasma lipid profiles and behavioral parameters were also assessed.

Results

Plasma lipids were slightly affected to a more atherogenic profile by orchiectomy, but atherosclerotic lesion size was unaltered in the LAD, thoracic aorta, abdominal aorta, and iliac arteries. The distribution of lesion types (xanthomas, pathological intimal thickening and fibroatheromas) were also not statistically different between groups in any of the examined vascular territories. The abdominal aorta developed the most advanced stages of disease with reproducible fibroatheroma formation, and here it was found that the area of necrotic core was significantly increased in orchiectomized pigs compared with controls. Orchiectomy also reduced aggressive behavior.

Conclusions

Castration does not alter the burden of atherosclerosis in hypercholesterolemic Yucatan minipigs, but may increase necrotic core area in fibroatheromas.

Background

Low serum testosterone levels are associated with increased atherosclerosis and risk of cardiovascular mortality, both in men with spontaneous age-associated serum testosterone decline [1], and in patients receiving androgen deprivation therapy (ADT) to control prostate cancer [2]. Meta-analysis of randomized clinical trials of ADT, on the other hand, has failed to replicate the finding from observational studies and causality of the association between castration and cardiovascular disease thus remains unresolved [3].

One prevailing hypothesis is that hypogonadism may increase cardiovascular risk through atherogenesis. This has been explored in mouse and rabbit models, where castration changes fat distribution, evokes more atherogenic lipid profiles, increases atherogenesis, and leads to changes in plaque composition with increased necrosis [47]. Recent studies in Apoe-deficient mice showed that loss of testosterone signaling in thymic epithelium was responsible for part of the pro-atherogenic effect [8]. Yet it remains unclear to what extent these effects of castration in mice and rabbits may translate to other models and indeed to human atherosclerosis.

Porcine models of atherosclerosis, including wildtype and gene-modified lines, develop lesions with high pathoanatomical resemblance to human lesions [9]. Because of its routine use in pork production or to avoid unsolicited breeding of commercial minipig lines, male pigs in experimental atherosclerosis experiments have often been castrated. Importantly, however, the effect of castration on atherosclerosis in pigs has never been analyzed, and it remains unknown how castration may have contributed to atherosclerosis phenotypes reported in the literature. In the present report, we analyzed the effect of castration on plasma lipids, atherosclerosis, and animal behavior in Yucatan minipigs with genetic hypercholesterolemia.

Methods

Animals

Procedures involving animals were approved by The Danish Animal Experiments Inspectorate (2015-15-0201-00570). Transgenic Yucatan minipigs with hepatic overexpression of a gain-of-function mutant of human proprotein convertase subtilisin/kexin type 9 (PCSK9D374Y) [10] were bred at the Department of Animal Science, Aarhus University. The animals were kept in a specific pathogen-free facility. Housing was initially in groups and later individually with visual, auditory, olfactory and tactile contact to other pigs.

A total of 20 male piglets were randomized to either bilateral orchiectomy performed 2–7 days after birth (n = 12) or serving as controls (n = 8). This number was estimated by a power analysis to detect a difference of 40% in aortic atherosclerosis (by en face examination) using variation estimates from a previous report [10]. Bilateral orchiectomy was performed after intramuscular injection of 5 mg flunixin meglumine per animal (a long-acting NSAID) as a pain relief. Testes were then removed through an incision through the overlying skin. Pigs were monitored by the stable facility staff and no acute complications to the procedure were observed.

The minipigs were fed a low-fat standard pig diet until 3 months of age and subsequently a high-fat high-cholesterol (HFHC) diet consisting of standard pig feed comprising 20% (w/w) of lard and 2% cholesterol (Sigma-Aldrich) until euthanization at 12 months of age. The diet was prepared by solubilizing the crystalline cholesterol in melted lard and mixing it with a standard feed for growing pigs containing 68.0% barley, 15.0% oat, 9.6% soy bean meal, 2.0% animal fat, 3.0% molasses, and 2.4% minerals and vitamins. Feeding was ad libitum until the pigs reached a weight of 20–25 kg and was then restricted to 700 g of feed per day divided into two daily portions.

The animals were monitored daily by the facility staff throughout the study period. Six pigs were lost from the study leaving final group sizes of 8 castrated pigs and 6 controls. Three pigs (2 castrated and 1 control) were euthanized because of the occurrence of scrotal hernias. Hernias were endemic in our Yucatan minipig colony at the time, but was greatly mitigated by changing breeders suggesting that it was genetic and not a complication to the orchiectomy. Three additional pigs were lost, two euthanized because of sickness (gastroenteritis) and one dead from an unknown cause.

Assessment of aggressive behavior

At 11 months of age, minipigs were transferred to single-pens in another stall with only males. Aggressive behavior in this setting was assessed by scoring 10 aggression parameters (yes/no scoring yielding a score from 0–10) defined in collaboration with the animal facility staff: Attempting to bite observer, biting bars on fence, pushing the observer, bumping into bars on fence, standing with front legs on top of fence, chewing noisily, digging with front legs, standing very upright, facing laterally to the observer, resists being pushed. The minipigs were also assessed for shyness of the observer (keeping a distance), which was considered a sign of non-aggression. Pigs were familiar with the observers, which were part of the daily animal staff caring for the pigs. Each minipig was assessed 1–4 times. Blinding was not possible because the lack of testes is obvious in orchiectomized pigs. An average score on each parameter was calculated for animals observed more than once. The overall total score of all aggression parameters was compared between castrated and control minipigs. Likewise, score on the non-aggression parameter, shyness of the observer, was compared between groups.

Plasma analysis

Blood was drawn in the morning from individual animals after an overnight fast and EDTA-plasma analyzed for total cholesterol, LDL cholesterol (direct method), HDL cholesterol (direct method), and triglycerides by standard procedures using an autoanalyzer ADVIA 1800® Chemistry System (Siemens Corporation, Tarrytown, NY 10591, USA). Intra- and inter assay precision were in all instances below 3 and 4 CV%, respectively. Plasma testosterone was analyzed in the blood samples collected at 3, 6, 9, and 12 months of age by immuno-chemical methods (Arbor Assays, K032-H1, Michigan 48108 USA). The instructions given by the manufacturer were followed. Coefficient of variation between replicates were in all instances below 12%, the limit of detection was confirmed to be at least 40 pg/mL.

Pathology

At the age of 12 months, the minipigs were sedated by intramuscular injection of midazolam (1 mg/kg) and azaperone (8mg/kg). 10.000 IU heparin was injected intravenously and animals were euthanized by a lethal dose of pentobarbital (4 mL/kg). Hearts were excised and immersed in 4% phosphate-buffered formaldehyde. The aortas were cut transversally between the branching of the 6th and 7th intercostal arteries to divide aortas into the thoracic and abdominal part. The two aortic specimens and the proximal 8 cm of the right iliac artery were cut open longitudinally and fixed on a polystyrene plate with needles before immersion in formaldehyde for 24 hours. All specimens were then kept in cold phosphate-buffered saline.

Aortas and right iliac arteries were stained with Sudan IV (Sigma-Aldrich; 5 g/liter in 96% ethanol in 5 minutes followed by 90 seconds washout in 96% ethanol) and en face images of the vessels were obtained using a digital scanner (Epson Perfection V600 Photo, Seiko Epson Corporation, Japan). In thoracic aortas and iliac arteries, the area fraction of intimal surface covered with lesions was determined by automated computer-assisted measurement of Sudan-IV stained (sudanophilic) intima using ImageJ 1.48v (National Institutes of Health, USA). Lesions in the abdominal aorta were traced manually using ImageJ since most of the raised lesions in this region were less sudanophilic.

For histological examination, left anterior descending (LAD) coronary arteries were excised from the myocardium and the proximal 3 cm were divided into six 5 mm segments. The most advanced lesion (by macroscopic inspection) in two regions of the abdominal aorta were also obtained. Lesions develop reproducibly in the distal aorta near the aortic trifurcation and a cross-sectional slice containing the most raised lesion in this region was selected. Furthermore, a cross-sectional slice containing the most raised lesion furthermore proximal in the abdominal aorta (typically near the renal arteries) were obtained. Segments were paraffin-embedded, sectioned for histological analysis, and stained with elastin-trichrome for morphometric analysis and morphological measurement. Plaque necrosis, defined as cell- and collagen-free areas in trichrome and Sirius Red-stained sections, was determined in abdominal aortic lesions.

Lesion and necrotic size were measured using ImageJ (NIH). For aortic plaques, maximum plaque-thickness was measured from the internal elastic lamina to the lumen. All microscopic analyses were performed blinded. Lesions were categorized according to the Virmani classification as normal, xanthoma, pathological intimal thickening or fibroatheroma [11].

Statistics

All statistical analyses were performed using Prism 6 (GraphPad Software Inc). Data are expressed as mean±SEM. The experimental units in all statistical comparisons were single animals. P-values were calculated using 2-tailed unpaired Student’s t-test (with Welch’s correction as indicated in figure legends) for normally distributed data (Shapiro-Wilk normality test). Area under the curve (AUC) was calculated by the trapezoidal method and compared between groups to test for differences in time serial measurements. For comparison of plaque types between groups, the most advanced plaque type recorded in each pig and arterial bed was compared among groups using Fisher’s exact test. P<0.05 was considered significant. Significant differences are marked with * in figures. Exact values for P<0.05 and P = 0.05–0.10 are given in text and in figure legends.

Results

Fourteen male PCSK9D374Y Yucatan minipigs were, by randomization, either orchiectomized (Orx) (n = 8) or served as controls (n = 6). Plasma testosterone was measured on blood samples collected at 3, 6, 9, and 12 months of age, and showed the expected increase around sexual maturation in intact minipigs. Orchiectomy reduced testosterone to castrate levels similar to those reached by ADT in humans (<0.2–0.5 ng/ml) (Fig 1A). Mean final body weights did not differ between groups (79.0±3.06 kg versus 77.3±3.83 kg), but orchiectomized males on average had thicker backfat compared with controls (69.1±3.49 mm versus 49.5±7.81 mm, P = 0.027).

Fig 1. Plasma measurements, plaque burden, and animal behavior.

Fig 1

A. Plasma testosterone levels in orchiectomized (Orx) and control PCSK9D374Y Yucatan minipigs. *P<0.0001 (t test on AUC). B. Plasma lipid levels on low-fat diet (3 months of age) and on HFHC diet (6, 9, and 12 months of age) was altered in castrated pigs with modestly increased LDL cholesterol (*P = 0.045, t test with Welch’s correction on AUC) and reduced HDL cholesterol (*P = 0.002, t test on AUC). The difference in plasma triglyceride burden over the course of study was not significant (P = 0.06, t test on AUC). C. Representative examples of Sudan red stained thoracic aorta (left), abdominal aorta (middle) and right iliac (right). D-F. Quantification of lesions as fraction of total vessel surface in thoracic aortas (D), abdominal aortas (E), and right iliac artery (F) showing no significant differences between groups. Data from the examples in (C) are marked in red. G. Representative examples of histology of iliac lesions stained with hematoxylin-eosin. Scale bars = 500 μm. H-I. Intimal/lesion areas measured on hematoxylin-eosin stained sections in right iliacs and LADs show no differences between groups. Data from the examples in (G) are marked in red. J. Scoring of aggressive behavior showed significant reduction in orchiectomized pigs. Each animal was observed one to four times. *P = 0.009 (t test with Welch’s correction). Number of data points/animals in each panel are 6 and 8 for the control and orchiectomized groups, respectively. Error bars indicate mean and SEM.

Plasma lipids were unaltered by orchiectomy at baseline when pigs were fed standard low-fat diet, but orchiectomized pigs developed higher plasma LDL cholesterol and triglycerides and lower plasma HDL cholesterol on high-fat, high-cholesterol diet over the course of study (Fig 1B).

Castration does not alter plaque burden

Atherosclerosis burden was evaluated by en face analysis of the thoracic aorta, abdominal aorta and right iliac artery, in serial cross-sections through the LAD and right iliac artery. The surface of the thoracic aorta was mainly covered by non-raised sudanophilic fatty streaking (≈45% surface area), while the abdominal had predominantly raised lesions (≈30% or surface area) (Fig 1C). Lesions in the right iliac artery spanned from fatty streaks to small raised lesions (≈30% in total). Fractional lesion area was not statistically altered by orchiectomy in any of the vascular beds (Fig 1D–1F). Consistently, average intimal area was not significantly affected by orchiectomy in the LAD and right iliac artery (Fig 1G–1I).

Castration reduces aggressive behavior in PCSK9D374Y minipigs

Animals where evaluated on aggressive behavior within the last month before euthanization when they were housed in single-pens in stalls with only males. Orchiectomized minipigs exhibited less aggressive behavior than controls as measured by the average score of 10 aggression parameters (Fig 1J). The positive non-aggression parameter (shyness of the observer) was not altered significantly.

Plaque necrosis in fibroatheromas increased in orchiectomized minipigs

Morphological analysis of lesions in the LAD and right iliac arteries showed mostly early atherosclerotic lesion types consisting of foam cell lesions and pathological intimal thickenings (Fig 2A), and there were no statistically significant differences between groups. To probe for lesion composition at a more advanced stage of atherosclerosis, we did further histological analysis at two sites in the atherosclerosis-susceptible abdominal aorta. A blinded observer harvested the most raised lesion in close proximity to the aortic trifurcation and the most raised lesion in the more proximal part of the abdominal aorta. The majority of lesions were pathological intimal thickenings and fibroatheromas (progressive lesions) and there was no difference in frequency distribution (progressive versus non-progressive nor fibroatheromas versus non-fibroatheromas) between orchiectomized and control animals (Fig 2A). Lesion thickness (a proxy for plaque size) was not affected by castration in the aortic trifurcation nor in the proximal abdominal aortic lesion (Fig 2B). However, analysis of necrotic core formation in the aortic lesions, quantified as the fraction of collagen-free lesion areas in Sirius Red-stained histological sections, revealed a significant higher amount of necrosis in castrated compared with control minipigs (Fig 2C–2E).

Fig 2. Plaque typing and core formation.

Fig 2

A. Lesion type (Virmani classification) of sections from the LAD, right iliac and abdominal aorta. For statistical analysis, the most advanced lesion type found in each animal was compared between groups. Differences were not statistically significant (Fisher’s exact tests). B. Thickness of the most raised lesions in the distal abdominal aorta close to the trifurcation and further proximal were similar between groups. C. Plaque necrosis in abdominal aorta lesions (mean of necrosis at the two aortic sites) were significantly increased in castrated animals. *P = 0.036 (t-test with Welch’s correction). D-E. Representative images (indicated by red dots in B-C) of trichrome- and Sirius Red-stained histological sections of abdominal aorta lesions. Scale bars = 1 mm. Number of data points/animals in each panel are 6 and 8 for the control and orchiectomized groups, respectively. Error bars indicate mean and SEM.

Discussion

In the present study, we tested the effects of perinatal surgical orchiectomy on the development of atherosclerosis in hypercholesterolemic PCSK9D374Y Yucatan minipigs. Orchiectomy led to plasma testosterone at castrate levels defined for human ADT and caused a more atherogenic lipid profile with higher LDL-cholesterol levels similar to what has been reported for hypogonadal men [2]. Atherosclerotic lesion size was not changed in any vascular bed, but at the most atherosclerosis-prone site examined in the abdominal aorta, where fibroatheroma development was frequent at the time point examined, significantly larger necrotic cores were found in castrated minipigs.

The analysis of castration effects fills a knowledge gap in the field of porcine atherosclerosis models. Porcine models have been used for decades for atherosclerosis research, and animals have frequently been castrated for various reasons, but the effects that castration may exert on lesion development has not been addressed. This is not merely a technical point that hinders comparison of different approaches to lesion induction and must be factored into the interpretation of previous pig studies. Effects of castration in experimental models may also point to potential causal mechanisms underlying the association of androgen deprivation therapy, or spontaneous hypogonadism, with coronary events [1,2].

Overall, we found modest effects of castration on plasma lipids and plaque burden in minipigs compared to what has been reported in mice and rabbits [48]. As an investigation into the human association of hypogonadism and coronary events, our investigation is unfortunately limited by the scarcity of advanced coronary lesions in the present study. The augmented plaque necrosis that we found in the most advanced lesions of the abdominal aorta in castrated minipigs may, however, be interesting in that respect, because it is consistent with observations in advanced murine atherosclerosis. In fibroatheromatous lesions induced by flow-disturbing collars in Apoe-knockout mice, Knutson et al. found that castration through GnRH agonism increased necrotic core size without changes in lesion burden [7]. Another study in Apoe-knockout mice also demonstrated an androgen receptor-dependent effect of testosterone on necrotic core formation [12]. If castration facilitates necrosis in coronary lesions in humans, this may be a credible mechanism for the relatively rapid onset of the increased risk of heart attack after ADT [13,14]. It would be interesting in future studies to investigate the short-term effects on plaque necrosis when castration is induced in older PCSK9D374Y males with advanced, pre-existing coronary atherosclerosis to test this hypothesis more directly. Such further studies are also warranted since the analysis of abdominal aorta plaque necrosis was an ad hoc finding of the present investigation and not one of the pre-specified analyses.

Although castration in the present study was related to changes in LDL and HDL, the relatively small size of that effect and the absence of changes in plaque burden, indicate that causes of increased plaque necrosis may well be lipid-independent effects. Androgen receptors are present on many cell types in the atherosclerotic lesion, including macrophages, endothelial cells and smooth muscle cells [15]. Previously reported effects of testosterone deficiency, which conceivably could be involved in plaque necrosis, include heightened inflammation by macrophages or T cells [8,16], and reduced reverse cholesterol transport from foam cell macrophages [17]. GnRH receptors are also present on cells partaking in atherosclerotic plaques and may potentially be stimulated by compensatory increases in GnRH levels that result from orchiectomy [7].

The results obtained in the HFHC-fed PCSK9D374Y transgenic minipigs may not necessarily extend to all pig models used for atherosclerosis research. Male castration has previously been shown to lead to obesity and decreased insulin sensitivity in adult Göttingen minipigs [18]. It is possible that such metabolic changes contribute to the atherosclerosis phenotype that can be induced in castrated male Göttingen minipigs by high-fat, high-cholesterol diet [19]. The restrictive feeding regimen of the present study may help explain why we observed no changes in body weight and only a moderate increase in backfat thickness in castrated PCSK9D374Y transgenic minipigs. Genetic background may also be important, and Yucatan minipigs are known to develop less metabolic changes on high energy diets than Ossabaw minipigs, which are also used for atherosclerosis research [20,21].

Perinatal orchiectomy of boars is standard practice in industrial livestock to prevent a strong undesirable flavor of pork. It also comes with benefits in animal handling and welfare, since entire male pigs exhibit more aggressive behavior causing injuries, especially after sexual maturation. In our work, we confirmed a clear aggression-reducing effect of orchiectomy in PCSK9D374Y Yucatan minipigs. Atherosclerosis studies are long term and include extended periods working with sexually mature animals, and animal aggressive behavior is a considerable concern in the work environment for facility staff members. Aggressive behavior is also likely to reduce animal welfare, among other things because it necessitates individual housing of animals. Castration may thus be warranted to improve the working environment as well as animal welfare in preclinical porcine studies of atherosclerosis involving males.

Study limitations

The relatively small number of animals may have masked our ability to detect some effects of castration on plasma lipids and atherosclerosis traits. Furthermore, as a model to understand effects on atherosclerosis of ADT in humans, pigs like other non-primate models are limited by differences in sex hormone physiology [18]. Another limitation of our study is the lack of advanced coronary atherosclerosis, including thin-cap fibroatheromas that would provide a more direct model of the type of atherosclerosis that may cause excess cardiovascular events in persons with spontaneous hypogonadism or patients undergoing ADT.

Conclusion

In conclusion, we found orchiectomy to increase plaque necrosis in PCSK9D374Y Yucatan minipigs in the absence of changes in atherosclerosis burden and with only a sparse effect on the atherogenic lipid profile. It also reduced signs of aggression. Together with previous studies in mouse models, our finding points to direct effects of castration on necrotic core formation.

Supporting information

S1 Checklist. The ARRIVE guidelines checklist.

(PDF)

Acknowledgments

We would like to thank Dorte Qualmann, Lisa Maria Røge, and Carsten Berthelsen for skilled technical assistance.

Abbreviations

ADT

Androgen deprivation therapy

APOE

Apolipoprotein E

AUC

Area under the curve

GnRH

Gonadotropin-Releasing Hormone

HDL

High-density lipoprotein

HFHC

High-fat high-cholesterol (diet)

LAD

Left anterior descending (coronary artery)

LDL

Low-density lipoprotein

LDLR

Low-density lipoprotein receptor

Orx

Orchiectomized

PCSK9

Proprotein convertase subtilisin/kexin type 9

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The study was funded by a grant from the Danish Independent Research Council (Sapere Aude Programme, 4004-00459B) and a fellowship from The Graduate School of Health, Aarhus University, Aarhus, Denmark. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Tivesten Å, Pinthus JH, Clarke N, Duivenvoorden W, Nilsson J. Cardiovascular risk with androgen deprivation therapy for prostate cancer: Potential mechanisms. Urol Oncol Semin Orig Investig. 2015;33(11):464–75. [DOI] [PubMed] [Google Scholar]
  • 2.Levine GN, D’Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, et al. Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology. Circulation. 2010;121(6):833–40. 10.1161/CIRCULATIONAHA.109.192695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hu JR, Duncan MS, Morgans AK, Brown JD, Meijers WC, Freiberg MS, et al. Cardiovascular effects of androgen deprivation therapy in prostate cancer: contemporary meta-analyses. Arterioscler Thromb Vasc Biol. 2020;40(3):e55–64. 10.1161/ATVBAHA.119.313046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C. Natural androgens inhibit male atherosclerosis: A study in castrated, cholesterol-fed rabbits. Circ Res. 1999;84(7):813–9. 10.1161/01.res.84.7.813 [DOI] [PubMed] [Google Scholar]
  • 5.Poulsen CB, Mortensen MB, Koechling W, Sørensen CB, Bentzon JF. Differences in hypercholesterolemia and atherogenesis induced by common androgen deprivation therapies in male mice. J Am Heart Assoc. 2016;5(2):e002800 10.1161/JAHA.115.002800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Nathan L, Shi W, Dinh H, Mukherjee TK, Wang X, Lusis AJ, et al. Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci U S A. 2001;98(6):3589–93. 10.1073/pnas.051003698 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Knutsson A, Hsiung S, Celik S, Rattik S, Mattisson IY, Wigren M, et al. Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE(-/-) mice. Sci Rep. 2016;6(April):26220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wilhelmson AS, Lantero Rodriguez M, Svedlund Eriksson E, Johansson I, Fogelstrand P, Stubelius A, et al. Testosterone protects against atherosclerosis in male mice by targeting thymic epithelial cells—Brief report. Arterioscler Thromb Vasc Biol. 2018;38(7):1519–27. 10.1161/ATVBAHA.118.311252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Shim J, Al-Mashhadi RH, Sørensen CB, Bentzon JF. Large animal models of atherosclerosis—new tools for persistent problems in cardiovascular medicine. J Pathol. 2016;238(2):257–66. 10.1002/path.4646 [DOI] [PubMed] [Google Scholar]
  • 10.Al-Mashhadi RH, Sorensen CB, Kragh PM, Christoffersen C, Mortensen MB, Tolbod LP, et al. Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant. Sci Transl Med. 2013;5(166):166ra1. [DOI] [PubMed] [Google Scholar]
  • 11.Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death : a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20(5):1262–75. 10.1161/01.atv.20.5.1262 [DOI] [PubMed] [Google Scholar]
  • 12.Bourghardt J, Wilhelmson ASK, Alexanderson C, De Gendt K, Verhoeven G, Krettek A, et al. Androgen receptor-dependent and independent atheroprotection by testosterone in male mice. Endocrinology. 2010;151(11):5428–37. 10.1210/en.2010-0663 [DOI] [PubMed] [Google Scholar]
  • 13.Albertsen PC, Klotz L, Tombal B, Grady J, Olesen TK, Nilsson J. Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist. Eur Urol. 2014;65(3):565–73. 10.1016/j.eururo.2013.10.032 [DOI] [PubMed] [Google Scholar]
  • 14.O’Farrell S, Garmo H, Holmberg L, Adolfsson J, Stattin P, Van Hemelrijck M. Risk and timing of cardiovascular disease after androgen-deprivation therapy in men with prostate cancer. J Clin Oncol. 2015;33(11):1243–51. 10.1200/JCO.2014.59.1792 [DOI] [PubMed] [Google Scholar]
  • 15.Huang CK, Lee SO, Chang E, Pang H, Chang C. Androgen receptor (AR) in cardiovascular diseases. J Endocrinol. 2016;229(1):R1–16. 10.1530/JOE-15-0518 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Freeman BM, Mountain DJH, Brock TC, Chapman JR, Kirkpatrick SS, Freeman MB, et al. Low testosterone elevates interleukin family cytokines in a rodent model: A possible mechanism for the potentiation of vascular disease in androgen-deficient males. J Surg Res. 2014;190(1):319–27. 10.1016/j.jss.2014.03.017 [DOI] [PubMed] [Google Scholar]
  • 17.Langer C, Gansz B, Goepfert C, Engel T, Uehara Y, Von Dehn G, et al. Testosterone up-regulates scavenger receptor bi and stimulates cholesterol efflux from macrophages. Biochem Biophys Res Commun. 2002;296(5):1051–7. 10.1016/s0006-291x(02)02038-7 [DOI] [PubMed] [Google Scholar]
  • 18.Christoffersen BO, Gade LP, Golozoubova V, Svendsen O, Raun K. Influence of castration-induced testosterone and estradiol deficiency on obesity and glucose metabolism in male Göttingen minipigs. Steroids. 2010;75(10):676–84. 10.1016/j.steroids.2010.04.004 [DOI] [PubMed] [Google Scholar]
  • 19.Ludvigsen TP, Kirk RK, Christoffersen BØ, Pedersen HD, Martinussen T, Kildegaard J, et al. Göttingen minipig model of diet-induced atherosclerosis: influence of mild streptozotocin-induced diabetes on lesion severity and markers of inflammation evaluated in obese, obese and diabetic, and lean control animals. J Transl Med. 2015;13(1):312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Neeb ZP, Edwards JM, Alloosh M, Long X, Mokelke EA, Sturek M. Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine. Comp Med. 2010;60(4):300–15. [PMC free article] [PubMed] [Google Scholar]
  • 21.Yuan F, Guo L, Park KH, Woollard JR, Taek-Geun K, Jiang K, et al. Ossabaw pigs with a PCSK9 gain-of-function mutation develop accelerated coronary atherosclerotic lesions: A novel model for preclinical studies. J Am Heart Assoc. 2018;7(6). [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Michael Bader

3 Apr 2020

PONE-D-20-06819

Effects of Castration on Atherosclerosis and Aggressive Behavior in Yucatan Minipigs with Genetic Hypercholesterolemia

PLOS ONE

Dear Dr. Bentzon,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by May 18 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Michael Bader

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

1. As part of your revision, please complete and submit a copy of the ARRIVE Guidelines checklist, a document that aims to improve experimental reporting and reproducibility of animal studies for purposes of post-publication data analysis and reproducibility: https://www.nc3rs.org.uk/arrive-guidelines. Please include your completed checklist as a Supporting Information file. Note that if your paper is accepted for publication, this checklist will be published as part of your article.

2. We note that you have a patent relating to material pertinent to this article. Please provide an amended statement of Competing Interests to declare this patent (with details including name and number), along with any other relevant declarations relating to employment, consultancy, patents, products in development or modified products etc. Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

This information should be included in your cover letter; we will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Shim et al. have studied the effects of neonatal castration on atherosclerosis and aggressive behavior in yucatan minipigs with genetic hypercholesterolemia. The study is well performed and adequately discussed.

I have only a few minor points.

1. Background, page 4, line 10: Remove the words ”through changes in T cell maturation”.

2. Were any samples below LOD of the testosterone assay?

3. Insert a reference or a more detailed description of Virmani classification of plaque morphology.

4. Replace the rather old reference 3 with a recent review (Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):e55-e64. doi: 10.1161/ATVBAHA.119.313046. Epub 2020 Jan 23. Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses.)

5. Discussion: Not only GnRH agonist but also direct testosterone/AR-mediated modulation of necrotic core has been shown in mouse models (Bourghardt et al. Endocrinology. 2010 Nov;151(11):5428-37).

6. The authors mention species differences in sex hormone physiology. Which are they? Clarify or at least insert a reference.

Reviewer #2: Letter of comments for authors

The authors present a paper, evaluating the effect of castration on atherogenesis and behavior in Yucatan minipigs. The content of the paper is overall interesting and of relevance from a model development point of view; in particular considering atherosclerosis studies in pigs being costly and time consuming where standard approaches done for e.g. practical reasons (such as castration), may have an impact on the disease progression. The data presented include lipid levels, histology incl. morphology and morphometric measures in both aorta and LAD. The data is presented well and accurately in the figures and pictures. Additionally, the animals have been observed with regards to behavior before and after castration.

The conclusion of the study is that modest effects of castration is observed on plasma lipids and plaque burden in minipigs.

The text presents with some deficiencies in terms of method description and aspects discussed. Additionally, the text should be revised with regards to wordings, grammatic and in general be more concise and accurate. Also check that referred methods software and systems are described according to guidelines of the journal.

Recommendation: For publication the paper should go through a major review in order to focus the aim, discussion and perspective of the study.

Specific inquires:

Title: Suggestion that the title should cover the primary focus of the study – is this to evaluate effects on behavior or atherogenesis? Proposal to narrow this down to the latter and include the behavioral aspect to be as part of perspective of the model. Also, the conclusion only touches on the atherogenesis part, supporting to narrow the main scope of the study.

Abstract: Please include up-front the number of animals evaluated as well as age and duration of study, for the reader to quickly understand what the results show.

Introduction: Although it may be correct that effect of neutralization has not been systematically evaluated in pig models, it should be taken into consideration and referred that effects on metabolic syndrome and obesity has been evaluated systematically in Göttingen Minipigs (e.g. Christoffersen BO Steroids. 2010 Oct;75(10):676-84. doi:10.1016/j.steroids. 2010.04.004. – other more novel papers may refer to this).

Methods: Please provide more details on orchiectomy: Was the anesthesia per animal or per weight? Local anesthesia? How were they monitored? Any posttreatment analgesia? Can be in supplementary section.

Please provide details as to feeding and dietary composition as pathology is driven by diet.

Please provide reference as to assessment scheme for behavioral observations. Is this a standard assessment in the species?

Please provide details to observer: is this a person the animals are familiar with or not?

Please state how “shyness” is scored. This is a subjective term

Lipoprotein fraction data is presented but method of assessment not specified. Please include this methodology.

It is apparent from reading the result section that evaluation of aortic lesions was done to ensure advanced lesions – however it is a little confusing from the method section that this is what has been done. The authors should clarify the following section in methods to avoid confusion.

“Two plaques in the abdominal aortas were also obtained: One distal, transversal segment containing the most raised lesion (by macroscopic inspection) in the region close to the aortic trifurcation, and one proximal segment containing the most raised lesion further proximal in the abdominal aorta.”

Provide reference to “Lesions were categorized according to the Virmani classification as normal, xanthoma, pathological intimal thickening or fibroatheroma.”

For statistical analyses: Has data been tested for normal distribution? Consider executing a repeated measure multivariate analyses instead of t-test of AUC and include LDL-C as explanatory variable to address whether observed differences in necrotic core could be explained by LDL cholesterol differences, although only subtle differences are observed.

Results:

Figures: Well-illustrated figures and figures and in particular very useful to show all data points (in the unpaired data, where it makes sense) including from what individual histology is depicted.

Figure 1 legend: Please include what histological staining that is used H-I.

Text: If direct measures of body composition specifically fat% is available from these animals, this would be highly relevant.

For the headline please rephrase the word “facilitate” (“Castration facilitates plaque necrosis in fibroatheromas”).

Discussion: Again, as stated for the introduction, previous studies in minipigs should be taken into consideration. Additionally, beside the studies exploring effects of castration, discussion of breed susceptibility could also be taken in, with reference to the e.g. Neeb et al suggesting the Yucatan to be less prone to metabolic syndrome compared to Ossabaw pigs (Neeb Z et al Comp Med. 2010 Aug; 60(4): 300–315. PMID: 20819380). The finding of no difference in bodyweight between the two groups is somewhat surprising.

Rephrase “…castration facilitates atherosclerosis..” – the data presented suggests an association between castrated animals and increased necrotic core, but actual mechanistic studies to cover the underlying biology has not been executed.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Jun 5;15(6):e0234131. doi: 10.1371/journal.pone.0234131.r002

Author response to Decision Letter 0


6 May 2020

Editor comments

1. As part of your revision, please complete and submit a copy of the ARRIVE Guidelines checklist, a document that aims to improve experimental reporting and reproducibility of animal studies for purposes of post-publication data analysis and reproducibility: https://www.nc3rs.org.uk/arrive-guidelines. Please include your completed checklist as a Supporting Information file. Note that if your paper is accepted for publication, this checklist will be published as part of your article.

Response: We have filled the ARRIVE Guidelines checklist and expanded on our description of animals and data analysis throughout the methods section.

2. We note that you have a patent relating to material pertinent to this article. Please provide an amended statement of Competing Interests to declare this patent (with details including name and number), along with any other relevant declarations relating to employment, consultancy, patents, products in development or modified products etc. Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, as detailed online in our guide for authorshttp://journals.plos.org/plosone/s/competing-interests by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Response: We have the patent on the D374Y-PCSK9 minipigs. The existence of this patent does not alter our adherence to PLOS ONE policies on sharing data and materials, which is now also stated in text.

Reviewer #1 comments

Shim et al. have studied the effects of neonatal castration on atherosclerosis and aggressive behavior in yucatan minipigs with genetic hypercholesterolemia. The study is well performed and adequately discussed.

Response: We thank the reviewer for the time and effort invested in reading and suggesting improvements and clarifications for our manuscript.

I have only a few minor points.

1. Background, page 4, line 10: Remove the words ”through changes in T cell maturation”.

Response: We have now removed this part of the sentence and we thank the reviewer for helping us making the point in this sentence clear.

2. Were any samples below LOD of the testosterone assay?

Response: We detected levels of testosterone in all samples; the lowest value we measured was 68.3 pg/ml (LOD was lower or equal to 40 pg/ml).

3. Insert a reference or a more detailed description of Virmani classification of plaque morphology.

Response: In the final sentence in the Methods section, we have now added the reference to the original paper by Virmani et al (reference 11) which contains a detailed description of the Virmani classification.

4. Replace the rather old reference 3 with a recent review (Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):e55-e64. doi: 10.1161/ATVBAHA.119.313046. Epub 2020 Jan 23. Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses.)

Response: We thank the reviewer for pointing out this new paper as an up-to-date reference. We have replaced this reference.

5. Discussion: Not only GnRH agonist but also direct testosterone/AR-mediated modulation of necrotic core has been shown in mouse models (Bourghardt et al. Endocrinology. 2010 Nov;151(11):5428-37).

Response: Thank you for correcting our omission of this important observation. We have referred to this work in the discussion of the revised manuscript (lines 247-248 and ref 12).

6. The authors mention species differences in sex hormone physiology. Which are they? Clarify or at least insert a reference.

Response: We have chosen to omit the part of the sentence in the introduction stating this. For the limitation sections we have added reference to Christoffersen B et al (ref 18) in which differences in estradiol/testosterone ratios between pigs and human are described.

Reviewer #2 comments

The authors present a paper, evaluating the effect of castration on atherogenesis and behavior in Yucatan minipigs. The content of the paper is overall interesting and of relevance from a model development point of view; in particular considering atherosclerosis studies in pigs being costly and time consuming where standard approaches done for e.g. practical reasons (such as castration), may have an impact on the disease progression. The data presented include lipid levels, histology incl. morphology and morphometric measures in both aorta and LAD. The data is presented well and accurately in the figures and pictures. Additionally, the animals have been observed with regards to behavior before and after castration.

The conclusion of the study is that modest effects of castration is observed on plasma lipids and plaque burden in minipigs.

The text presents with some deficiencies in terms of method description and aspects discussed. Additionally, the text should be revised with regards to wordings, grammatic and in general be more concise and accurate. Also check that referred methods software and systems are described according to guidelines of the journal.

Recommendation: For publication the paper should go through a major review in order to focus the aim, discussion and perspective of the study.

Response: We thank the reviewer for the time and effort invested in reading and suggesting improvements and clarifications for our manuscript.

Specific inquires:

Title: Suggestion that the title should cover the primary focus of the study – is this to evaluate effects on behavior or atherogenesis? Proposal to narrow this down to the latter and include the behavioral aspect to be as part of perspective of the model. Also, the conclusion only touches on the atherogenesis part, supporting to narrow the main scope of the study.

Response: Thank you for this suggestion. We agree that this could be a good idea and have changed the title to: “Effects of Castration on Atherosclerosis in Yucatan Minipigs with Genetic Hypercholesterolemia“.

Abstract: Please include up-front the number of animals evaluated as well as age and duration of study, for the reader to quickly understand what the results show.

Introduction: Although it may be correct that effect of neutralization has not been systematically evaluated in pig models, it should be taken into consideration and referred that effects on metabolic syndrome and obesity has been evaluated systematically in Göttingen Minipigs (e.g. Christoffersen BO Steroids. 2010 Oct;75(10):676-84. doi:10.1016/j.steroids. 2010.04.004. – other more novel papers may refer to this).

Response: Thank you for suggesting these improvements. We have inserted the number of animals as well as more information on experimental design. We have also rewritten the results section for clarity. The mention of other relevant endpoints affected by castration, including metabolic syndrome, has been incorporated in the discussion (lines 263-271)

Methods: Please provide more details on orchiectomy: Was the anesthesia per animal or per

weight? Local anesthesia? How were they monitored? Any posttreatment analgesia? Can be

in supplementary section.

Response: Orchiectomy was performed by a standard agricultural procedure with anesthesia in the facility that breeds our transgenic minipigs using a long-acting NSAID (flunixine meglumine). Anesthesia was per animal and the piglets were monitored by the stable staff afterwards. No posttreatment analgesia was given. Some animals outside those described in the paper were excluded from the study and euthanized because of the development of scrotal hernia (n=3). These hernias were occurring generally among the male pigs in the breeding colony at the time. After selecting other breeders from our colony for subsequent studies, we are seeing this rarely, including in castrated pigs. We therefore believe that it is genetic and not related to the procedure. In the present study it was seen in both castrated (n=2) and non-castrated pigs (n=1). We have edited the text to describe this. It can be found on lines 100-102 and lines 110-115).

Please provide details as to feeding and dietary composition as pathology is driven by diet.

Response: We have inserted more details about the diet and feeding regimen on lines 105-109. Pigs were fed ad libitum until they reached 20-25 kg of body weight and was thereafter fed 700 g of feed divided in two daily portions.

Please provide reference as to assessment scheme for behavioral observations. Is this a standard assessment in the species?

Response: This was an assessment scheme we developed in collaboration with the animal caretakers. To our knowledge there is no standard assessment scheme for pig aggressive behavior. We have inserted more detail about the assessment on lines 118-130.

Please provide details to observer: is this a person the animals are familiar with or not?

Response: The persons scoring the pigs were part of the daily animal staff and familiar to the pigs. We have added that information to lines 125-126.

Please state how “shyness” is scored. This is a subjective term

Response: “Shyness” was used to describe the behavior of pigs attempting to keep a distance to the observer at all times. This information has been added to lines 124-125.

Lipoprotein fraction data is presented but method of assessment not specified. Please include this methodology.

Response: LDL and HDL cholesterol were measured by the direct method using the standard assays for the Siemens ADVIA1800 autoanalyzer. This has now been added to the manuscript on lines 133-136.

It is apparent from reading the result section that evaluation of aortic lesions was done to ensure advanced lesions – however it is a little confusing from the method section that this is what has been done. The authors should clarify the following section in methods to avoid confusion.

“Two plaques in the abdominal aortas were also obtained: One distal, transversal segment containing the most raised lesion (by macroscopic inspection) in the region close to the aortic trifurcation, and one proximal segment containing the most raised lesion further proximal in the abdominal aorta.”

Response: As the reviewer notes, our goal was to look at the most advanced lesions in the abdominal aorta, which are also the most advanced lesions overall. We have rephrased the sentence so that it now reads: “The most advanced lesion (by macroscopic inspection) in two regions of the abdominal aorta were also obtained. Lesions develop reproducibly in the distal aorta near the aortic trifurcation and a cross-sectional slice containing the most raised lesion in this region was selected. Furthermore, a cross-sectional slice containing the most raised lesion furthermore proximal in the abdominal aorta (typically near the renal arteries) were obtained”. The revised text can be found on lines 157-165.

Provide reference to “Lesions were categorized according to the Virmani classification as normal, xanthoma, pathological intimal thickening or fibroatheroma.”

Response: In the final sentence in the Methods section (lines 168-169), we have now added the reference to the original paper by Virmani et al (reference 11) which contains a detailed description of the Virmani classification.

For statistical analyses: Has data been tested for normal distribution? Consider executing a repeated measure multivariate analyses instead of t-test of AUC and include LDL-C as explanatory variable to address whether observed differences in necrotic core could be explained by LDL cholesterol differences, although only subtle differences are observed.

Response: Yes, data was tested for normal distribution with the Shapiro-Wilk normality test and this information is now included in the statistics section on lines 172-180. We appreciate the suggestion to do repeated measures ANOVA on the plasma lipid data. The reason that we prefer the AUC approach is that this type of statistics fits well with the biological understanding of the connection between plasma lipids and atherosclerosis, i.e. that it is the cumulative exposure that is important for the amount of atherosclerosis. We did not find any significant correlation between LDL cholesterol (measured as area-under-the-curve over the course of study) and plaque necrosis:

Results:

Figures: Well-illustrated figures and figures and in particular very useful to show all data

points (in the unpaired data, where it makes sense) including from what individual histology is depicted.

Figure 1 legend: Please include what histological staining that is used H-I.

Response: We have added that the images in panel G are stained with hematoxylin-eosin, and that H-I is data measured on hematoxylin-eosin-stained sections.

Text: If direct measures of body composition specifically fat% is available from these animals, this would be highly relevant.

Response: We appreciate this suggestion, but unfortunately, we do not have that information.

For the headline please rephrase the word “facilitate” (“Castration facilitates plaque necrosis in fibroatheromas”).

Response: We appreciate this advice and have rephrased to “Plaque necrosis increased in fibroatheromas of orchiectomized pigs”

Discussion: Again, as stated for the introduction, previous studies in minipigs should be taken into consideration. Additionally, beside the studies exploring effects of castration, discussion of breed susceptibility could also be taken in, with reference to the e.g. Neeb et al suggesting the Yucatan to be less prone to metabolic syndrome compared to Ossabaw pigs (Neeb Z et al Comp Med. 2010 Aug; 60(4): 300–315. PMID: 20819380). The finding of no difference in bodyweight between the two groups is somewhat surprising.

Response: We have added a section discussing the effect of castration on metabolic parameters in pigs and the effect of breed on lines 263-271. In that context we have also discussed the importance of ad libitum versus restricted feeding.

Rephrase “…castration facilitates atherosclerosis..” – the data presented suggests an association between castrated animals and increased necrotic core, but actual mechanistic studies to cover the underlying biology has not been executed.

Response: We agree with the reviewer and have changed the headline in the results section. I do not think that we make that statement about our data in any other parts of the manuscript.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Michael Bader

20 May 2020

Effects of Castration on Atherosclerosis in Yucatan Minipigs with Genetic Hypercholesterolemia

PONE-D-20-06819R1

Dear Dr. Bentzon,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Michael Bader

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Acceptance letter

Michael Bader

27 May 2020

PONE-D-20-06819R1

Effects of Castration on Atherosclerosis in Yucatan Minipigs with Genetic Hypercholesterolemia

Dear Dr. Bentzon:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Michael Bader

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. The ARRIVE guidelines checklist.

    (PDF)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES